Agribusiness
DANONE
Ticker: BN
|
Exchange: FP
|
Composite FIGI: BBG000BBY1B0
Total Alternative Signals
1signals tracked
Weighted Sentiment
+0.70weighted index
Avg Materiality Score
3.0/ 5.0 scale
Signal Distribution
1▲|0■|0▼
Alternative Data Signal Feed
Unlock Alternative Signals Feed
Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for DANONE. Programmatic API and Webhooks available.
Patent FilingBullish
Filing Date: 2026-06-21
Signal Event Report - FIGI BBG000BBY1B0
Compagnie Gervais Danone, a related entity of Danone, was granted a patent for the use of Akkermansia muciniphila or its fragments in treating metabolic disorders, indicating innovation in health and nutrition.
Quantitative Investment Thesis
This patent strengthens Danone's intellectual property portfolio in the health and wellness sector, specifically targeting metabolic disorders, which could lead to new product development and future revenue streams, enhancing the long-term investment case.
Materiality & Sentiment Scores
Sentiment: 0.7
Materiality: 3 / 5
Source Document: https://patents.justia.com/assignee/danone-s-a